

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.49175038 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.90809332 |
| 3 | cardiac myofibril assembly (GO:0055003) | 6.71582990 |
| 4 | tricarboxylic acid cycle (GO:0006099) | 6.69986797 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.36978818 |
| 6 | myofibril assembly (GO:0030239) | 5.99719890 |
| 7 | actin-myosin filament sliding (GO:0033275) | 5.98981974 |
| 8 | muscle filament sliding (GO:0030049) | 5.98981974 |
| 9 | plasma membrane repair (GO:0001778) | 5.82223423 |
| 10 | cardiac muscle contraction (GO:0060048) | 5.70384293 |
| 11 | carnitine shuttle (GO:0006853) | 5.64094812 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.16095383 |
| 13 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.03574774 |
| 14 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.03087028 |
| 15 | cardiac muscle cell development (GO:0055013) | 5.00733178 |
| 16 | regulation of skeletal muscle contraction (GO:0014819) | 4.98882115 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.88315958 |
| 18 | fatty acid transmembrane transport (GO:1902001) | 4.88024832 |
| 19 | NADH metabolic process (GO:0006734) | 4.84371488 |
| 20 | mannose metabolic process (GO:0006013) | 4.83982865 |
| 21 | actomyosin structure organization (GO:0031032) | 4.83122257 |
| 22 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.79871991 |
| 23 | 2-oxoglutarate metabolic process (GO:0006103) | 4.77861906 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 4.76954455 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 4.76954455 |
| 26 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.76725344 |
| 27 | actin-mediated cell contraction (GO:0070252) | 4.74351036 |
| 28 | cardiac cell development (GO:0055006) | 4.66105122 |
| 29 | regulation of actin filament-based movement (GO:1903115) | 4.58327579 |
| 30 | striated muscle contraction (GO:0006941) | 4.58263307 |
| 31 | lysine metabolic process (GO:0006553) | 4.47251947 |
| 32 | lysine catabolic process (GO:0006554) | 4.47251947 |
| 33 | carnitine transmembrane transport (GO:1902603) | 4.44504995 |
| 34 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.44193453 |
| 35 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.43212489 |
| 36 | creatine metabolic process (GO:0006600) | 4.29727566 |
| 37 | amino-acid betaine transport (GO:0015838) | 4.26938692 |
| 38 | carnitine transport (GO:0015879) | 4.26938692 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25974972 |
| 40 | heart trabecula formation (GO:0060347) | 4.23312370 |
| 41 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.22467576 |
| 42 | cardiac muscle hypertrophy (GO:0003300) | 4.21138813 |
| 43 | regulation of relaxation of muscle (GO:1901077) | 4.20337997 |
| 44 | regulation of cofactor metabolic process (GO:0051193) | 4.19164269 |
| 45 | regulation of coenzyme metabolic process (GO:0051196) | 4.19164269 |
| 46 | aspartate family amino acid catabolic process (GO:0009068) | 4.18167259 |
| 47 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.14935822 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 4.13802352 |
| 49 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.13261272 |
| 50 | oxaloacetate metabolic process (GO:0006107) | 4.12036502 |
| 51 | adult heart development (GO:0007512) | 4.11044458 |
| 52 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.08569174 |
| 53 | striated muscle hypertrophy (GO:0014897) | 4.05213277 |
| 54 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.04602499 |
| 55 | cell communication involved in cardiac conduction (GO:0086065) | 3.97097608 |
| 56 | GDP-mannose metabolic process (GO:0019673) | 3.96863088 |
| 57 | regulation of membrane repolarization (GO:0060306) | 3.96039994 |
| 58 | regulation of fatty acid oxidation (GO:0046320) | 3.94439816 |
| 59 | oxidative phosphorylation (GO:0006119) | 3.93460944 |
| 60 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.90124295 |
| 61 | cell communication by electrical coupling (GO:0010644) | 3.90115888 |
| 62 | protein retention in ER lumen (GO:0006621) | 3.81079023 |
| 63 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.80105285 |
| 64 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.76204520 |
| 65 | muscle tissue morphogenesis (GO:0060415) | 3.74537926 |
| 66 | succinate metabolic process (GO:0006105) | 3.73694017 |
| 67 | regulation of the force of heart contraction (GO:0002026) | 3.73533778 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 3.71944872 |
| 69 | actin filament-based movement (GO:0030048) | 3.67386937 |
| 70 | NIK/NF-kappaB signaling (GO:0038061) | 3.66360658 |
| 71 | proline biosynthetic process (GO:0006561) | 3.65172436 |
| 72 | negative regulation of cell size (GO:0045792) | 3.63357231 |
| 73 | heart contraction (GO:0060047) | 3.62153826 |
| 74 | heart process (GO:0003015) | 3.62153826 |
| 75 | regulation of striated muscle contraction (GO:0006942) | 3.60284471 |
| 76 | negative regulation of potassium ion transport (GO:0043267) | 3.58432985 |
| 77 | regulation of sarcomere organization (GO:0060297) | 3.52879330 |
| 78 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.49300176 |
| 79 | muscle hypertrophy (GO:0014896) | 3.47029522 |
| 80 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.40838414 |
| 81 | valine metabolic process (GO:0006573) | 3.35466135 |
| 82 | regulation of sequestering of triglyceride (GO:0010889) | 3.35227659 |
| 83 | cardiac muscle cell action potential (GO:0086001) | 3.32467363 |
| 84 | mitochondrial fusion (GO:0008053) | 3.31833922 |
| 85 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.29928409 |
| 86 | muscle hypertrophy in response to stress (GO:0003299) | 3.29928409 |
| 87 | cardiac muscle adaptation (GO:0014887) | 3.29928409 |
| 88 | UV protection (GO:0009650) | 3.29733350 |
| 89 | 4-hydroxyproline metabolic process (GO:0019471) | 3.25132548 |
| 90 | regulation of ATP catabolic process (GO:1903289) | 3.23984332 |
| 91 | regulation of ATPase activity (GO:0043462) | 3.23984332 |
| 92 | regulation of cell communication by electrical coupling (GO:0010649) | 3.23721653 |
| 93 | quaternary ammonium group transport (GO:0015697) | 3.23283685 |
| 94 | regulation of sulfur metabolic process (GO:0042762) | 3.19470180 |
| 95 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.16590035 |
| 96 | acetyl-CoA metabolic process (GO:0006084) | 3.16001078 |
| 97 | skeletal muscle contraction (GO:0003009) | 3.13933753 |
| 98 | barbed-end actin filament capping (GO:0051016) | 3.12759907 |
| 99 | muscle contraction (GO:0006936) | 3.11290247 |
| 100 | apoptotic process involved in morphogenesis (GO:0060561) | 3.10683053 |
| 101 | regulation of heart rate (GO:0002027) | 3.09846150 |
| 102 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.08957997 |
| 103 | glycogen catabolic process (GO:0005980) | 3.08680524 |
| 104 | fatty acid catabolic process (GO:0009062) | 3.05668928 |
| 105 | basement membrane organization (GO:0071711) | 3.04962917 |
| 106 | regulation of necrotic cell death (GO:0010939) | 3.02710699 |
| 107 | cell-substrate adherens junction assembly (GO:0007045) | 3.01653166 |
| 108 | focal adhesion assembly (GO:0048041) | 3.01653166 |
| 109 | adherens junction assembly (GO:0034333) | 3.01031483 |
| 110 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.00831101 |
| 111 | striated muscle cell development (GO:0055002) | 3.00470410 |
| 112 | branched-chain amino acid catabolic process (GO:0009083) | 3.00026162 |
| 113 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.98995209 |
| 114 | branched-chain amino acid metabolic process (GO:0009081) | 2.98860447 |
| 115 | gluconeogenesis (GO:0006094) | 2.97531479 |
| 116 | regulation of extracellular matrix disassembly (GO:0010715) | 2.97481216 |
| 117 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.95870168 |
| 118 | protein localization to endosome (GO:0036010) | 2.94025450 |
| 119 | regulation of tight junction assembly (GO:2000810) | 2.94001245 |
| 120 | striated muscle adaptation (GO:0014888) | 2.93342758 |
| 121 | fatty acid oxidation (GO:0019395) | 2.92262335 |
| 122 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.91471693 |
| 123 | regulation of early endosome to late endosome transport (GO:2000641) | 2.90491600 |
| 124 | glucan catabolic process (GO:0009251) | 2.88708990 |
| 125 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.84421799 |
| 126 | pinocytosis (GO:0006907) | 2.83119564 |
| 127 | negative regulation of necroptotic process (GO:0060546) | 2.78613342 |
| 128 | activation of Rac GTPase activity (GO:0032863) | 2.75746683 |
| 129 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.73151147 |
| 130 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.72503238 |
| 131 | protein maturation by protein folding (GO:0022417) | 2.72399472 |
| 132 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.68546136 |
| 133 | modulation by symbiont of host cellular process (GO:0044068) | 2.68506434 |
| 134 | proline metabolic process (GO:0006560) | 2.66962546 |
| 135 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.66856156 |
| 136 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.66856156 |
| 137 | modulation by virus of host process (GO:0019054) | 2.65971715 |
| 138 | regulation of necroptotic process (GO:0060544) | 2.64760746 |
| 139 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.62200121 |
| 140 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.62155895 |
| 141 | positive regulation of nuclease activity (GO:0032075) | 2.60614739 |
| 142 | regulation of ARF GTPase activity (GO:0032312) | 2.60611875 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.60025117 |
| 144 | pentose-phosphate shunt (GO:0006098) | 2.59136354 |
| 145 | maternal placenta development (GO:0001893) | 2.58779122 |
| 146 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.58366490 |
| 147 | retrograde transport, endosome to Golgi (GO:0042147) | 2.55612942 |
| 148 | semaphorin-plexin signaling pathway (GO:0071526) | 2.55560163 |
| 149 | negative regulation of necrotic cell death (GO:0060547) | 2.54546903 |
| 150 | regulation of cholesterol metabolic process (GO:0090181) | 2.53903093 |
| 151 | positive regulation of protein dephosphorylation (GO:0035307) | 2.53435890 |
| 152 | positive thymic T cell selection (GO:0045059) | 2.53064562 |
| 153 | activation of MAPKKK activity (GO:0000185) | 2.49142692 |
| 154 | glucose catabolic process (GO:0006007) | 2.48255686 |
| 155 | activation of JUN kinase activity (GO:0007257) | 2.48062002 |
| 156 | positive regulation of myotube differentiation (GO:0010831) | 2.47689075 |
| 157 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.44313925 |
| 158 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.43258657 |
| 159 | actin filament depolymerization (GO:0030042) | 2.42844827 |
| 160 | thymic T cell selection (GO:0045061) | 2.41971388 |
| 161 | cell-substrate junction assembly (GO:0007044) | 2.40262321 |
| 162 | stress fiber assembly (GO:0043149) | 2.39408533 |
| 163 | urea cycle (GO:0000050) | 2.38972280 |
| 164 | monosaccharide biosynthetic process (GO:0046364) | 2.38287104 |
| 165 | positive regulation of receptor recycling (GO:0001921) | 2.37909214 |
| 166 | negative regulation of viral release from host cell (GO:1902187) | 2.37105768 |
| 167 | response to laminar fluid shear stress (GO:0034616) | 2.35036004 |
| 168 | cellular response to virus (GO:0098586) | 2.33340060 |
| 169 | glucose 6-phosphate metabolic process (GO:0051156) | 2.31988129 |
| 170 | hexose biosynthetic process (GO:0019319) | 2.31530397 |
| 171 | regulation of nuclease activity (GO:0032069) | 2.30353701 |
| 172 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.28041658 |
| 173 | atrioventricular valve morphogenesis (GO:0003181) | 2.27672815 |
| 174 | endothelial cell chemotaxis (GO:0035767) | 2.27479744 |
| 175 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.26800942 |
| 176 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.25740573 |
| 177 | fructose metabolic process (GO:0006000) | 2.24984053 |
| 178 | nitrogen cycle metabolic process (GO:0071941) | 2.24641071 |
| 179 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.23090765 |
| 180 | embryo implantation (GO:0007566) | 2.22892616 |
| 181 | response to peptidoglycan (GO:0032494) | 2.22030472 |
| 182 | positive regulation of histone deacetylation (GO:0031065) | 2.21085741 |
| 183 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.19349918 |
| 184 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.18972014 |
| 185 | protein targeting to plasma membrane (GO:0072661) | 2.18725894 |
| 186 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.18689929 |
| 187 | negative regulation of cell killing (GO:0031342) | 2.18556743 |
| 188 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.18556743 |
| 189 | modulation by virus of host morphology or physiology (GO:0019048) | 2.18154027 |
| 190 | adhesion of symbiont to host (GO:0044406) | 2.17990278 |
| 191 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.17961093 |
| 192 | urea metabolic process (GO:0019627) | 2.17618876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.86430111 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.30815213 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.12992178 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.10137708 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.83326262 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.54095287 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.49505889 |
| 8 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39450480 |
| 9 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.34677401 |
| 10 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.34677401 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.34232747 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.33108303 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.28857758 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15482589 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12145686 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09863308 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07140745 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.05722843 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.04377358 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.02942516 |
| 21 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.93508728 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87517943 |
| 23 | P68_20966046_ChIP-Seq_HELA_Human | 1.86745151 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.86031451 |
| 25 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.78103941 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73795066 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72673120 |
| 28 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.69092624 |
| 29 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.65755147 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60439009 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.59909894 |
| 32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.58743681 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58388535 |
| 34 | ATF3_27146783_Chip-Seq_COLON_Human | 1.56025490 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55743669 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55007841 |
| 37 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54227103 |
| 38 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.52542379 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52460827 |
| 40 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51948437 |
| 41 | * MAF_26560356_Chip-Seq_TH2_Human | 1.47880392 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47871965 |
| 43 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.47366958 |
| 44 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.45972190 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.45837194 |
| 46 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45005896 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.44702683 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43847431 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42982658 |
| 50 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.40903031 |
| 51 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.39860487 |
| 52 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39636914 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.39148332 |
| 54 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.39116116 |
| 55 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.38893735 |
| 56 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.38693826 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36659750 |
| 58 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35691025 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34194355 |
| 60 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.34145127 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34034821 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.33253403 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.31911316 |
| 64 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.31848913 |
| 65 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.31819364 |
| 66 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.31193978 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30633107 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.30107901 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29081614 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28341004 |
| 71 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28296719 |
| 72 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.27885637 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26596252 |
| 74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26536301 |
| 75 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.26535092 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26244672 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26131741 |
| 78 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24318855 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22711125 |
| 80 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.22269048 |
| 81 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.22117485 |
| 82 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.21874889 |
| 83 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.21711951 |
| 84 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21498608 |
| 85 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.20461521 |
| 86 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19956394 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18662024 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18560414 |
| 89 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18285133 |
| 90 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.17500138 |
| 91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.17256757 |
| 92 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.14353865 |
| 93 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13824317 |
| 94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.13262389 |
| 95 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12335361 |
| 96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10974055 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.10391622 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10274518 |
| 99 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.10195493 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10180937 |
| 101 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.09740098 |
| 102 | MAF_26560356_Chip-Seq_TH1_Human | 1.09377145 |
| 103 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.08547998 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08162450 |
| 105 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.07522160 |
| 106 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.07516903 |
| 107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06908120 |
| 108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.06847962 |
| 109 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06560797 |
| 110 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.05731756 |
| 111 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05640596 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05047644 |
| 113 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04952002 |
| 114 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04708338 |
| 115 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04092836 |
| 116 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03940607 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02904727 |
| 118 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.02676932 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02424894 |
| 120 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02204214 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02130590 |
| 122 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99768948 |
| 123 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98593211 |
| 124 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98008119 |
| 125 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95697339 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94033694 |
| 127 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.93747281 |
| 128 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.93389296 |
| 129 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93356385 |
| 130 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92791498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.86613371 |
| 2 | MP0003646_muscle_fatigue | 5.81272081 |
| 3 | MP0000751_myopathy | 4.97749084 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.74716383 |
| 5 | MP0005058_abnormal_lysosome_morphology | 4.03190190 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.85207320 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.77560897 |
| 8 | MP0000749_muscle_degeneration | 3.69069014 |
| 9 | MP0005330_cardiomyopathy | 3.42256686 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.04390382 |
| 11 | MP0004130_abnormal_muscle_cell | 2.71939737 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.70220404 |
| 13 | MP0002269_muscular_atrophy | 2.67710277 |
| 14 | MP0008260_abnormal_autophagy | 2.57953180 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.54004478 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.51344567 |
| 17 | MP0008775_abnormal_heart_ventricle | 2.47212102 |
| 18 | MP0003137_abnormal_impulse_conducting | 2.39605954 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.39601177 |
| 20 | MP0004233_abnormal_muscle_weight | 2.38025171 |
| 21 | MP0010630_abnormal_cardiac_muscle | 2.36320147 |
| 22 | MP0000747_muscle_weakness | 2.35288045 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 2.32883337 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.22995954 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 2.22995954 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.19004316 |
| 27 | MP0000759_abnormal_skeletal_muscle | 2.11424236 |
| 28 | MP0003436_decreased_susceptibility_to | 2.06273828 |
| 29 | MP0005670_abnormal_white_adipose | 2.04029039 |
| 30 | MP0005369_muscle_phenotype | 2.02858909 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.90232178 |
| 32 | MP0006138_congestive_heart_failure | 1.89159342 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.88323083 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.85770546 |
| 35 | MP0004484_altered_response_of | 1.85403980 |
| 36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.79375516 |
| 37 | MP0003303_peritoneal_inflammation | 1.76650487 |
| 38 | MP0002877_abnormal_melanocyte_morpholog | 1.69289316 |
| 39 | MP0004085_abnormal_heartbeat | 1.59466832 |
| 40 | MP0005076_abnormal_cell_differentiation | 1.57386609 |
| 41 | MP0000858_altered_metastatic_potential | 1.54460809 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.52350008 |
| 43 | MP0009278_abnormal_bone_marrow | 1.48985729 |
| 44 | MP0004510_myositis | 1.47946317 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.47218145 |
| 46 | MP0003828_pulmonary_edema | 1.45554177 |
| 47 | MP0004947_skin_inflammation | 1.44094801 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.41173723 |
| 49 | MP0001958_emphysema | 1.40308651 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.40128782 |
| 51 | MP0001873_stomach_inflammation | 1.38671987 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.38615409 |
| 53 | MP0005375_adipose_tissue_phenotype | 1.38448023 |
| 54 | MP0009840_abnormal_foam_cell | 1.37922587 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.35157265 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.34842022 |
| 57 | MP0005409_darkened_coat_color | 1.31297315 |
| 58 | MP0003763_abnormal_thymus_physiology | 1.27303700 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.23458814 |
| 60 | MP0002127_abnormal_cardiovascular_syste | 1.23155452 |
| 61 | MP0003091_abnormal_cell_migration | 1.22406109 |
| 62 | MP0008961_abnormal_basal_metabolism | 1.21824980 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.20245127 |
| 64 | MP0000266_abnormal_heart_morphology | 1.15834399 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.15577240 |
| 66 | MP0000685_abnormal_immune_system | 1.15328263 |
| 67 | MP0002249_abnormal_larynx_morphology | 1.11253143 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 1.10378310 |
| 69 | MP0004381_abnormal_hair_follicle | 1.09238290 |
| 70 | MP0002933_joint_inflammation | 1.09067360 |
| 71 | MP0004043_abnormal_pH_regulation | 1.08827722 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.06361027 |
| 73 | MP0003279_aneurysm | 1.05585617 |
| 74 | MP0005025_abnormal_response_to | 1.05214503 |
| 75 | MP0003075_altered_response_to | 1.05130294 |
| 76 | MP0001661_extended_life_span | 1.04836908 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.03470506 |
| 78 | MP0000003_abnormal_adipose_tissue | 1.02022831 |
| 79 | MP0005266_abnormal_metabolism | 1.01969495 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.01490712 |
| 81 | MP0006035_abnormal_mitochondrial_morpho | 1.00833009 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.97657036 |
| 83 | MP0002060_abnormal_skin_morphology | 0.97645462 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.96111479 |
| 85 | MP0005501_abnormal_skin_physiology | 0.94579460 |
| 86 | MP0002796_impaired_skin_barrier | 0.94494602 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.93411365 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.92028356 |
| 89 | MP0005023_abnormal_wound_healing | 0.91439747 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.88334074 |
| 91 | MP0000604_amyloidosis | 0.87868763 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.87606461 |
| 93 | MP0005000_abnormal_immune_tolerance | 0.87556851 |
| 94 | MP0000343_altered_response_to | 0.87415404 |
| 95 | * MP0002419_abnormal_innate_immunity | 0.86832881 |
| 96 | MP0002971_abnormal_brown_adipose | 0.85644064 |
| 97 | MP0002108_abnormal_muscle_morphology | 0.84070958 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.83283336 |
| 99 | MP0005166_decreased_susceptibility_to | 0.82645743 |
| 100 | MP0005083_abnormal_biliary_tract | 0.82642911 |
| 101 | MP0000681_abnormal_thyroid_gland | 0.82330241 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.81929908 |
| 103 | MP0004272_abnormal_basement_membrane | 0.81054062 |
| 104 | MP0005332_abnormal_amino_acid | 0.80729056 |
| 105 | MP0005387_immune_system_phenotype | 0.80681100 |
| 106 | MP0001790_abnormal_immune_system | 0.80681100 |
| 107 | MP0000733_abnormal_muscle_development | 0.78896264 |
| 108 | MP0001853_heart_inflammation | 0.78642108 |
| 109 | MP0002396_abnormal_hematopoietic_system | 0.77862292 |
| 110 | MP0005165_increased_susceptibility_to | 0.77265800 |
| 111 | MP0001243_abnormal_dermal_layer | 0.76948009 |
| 112 | MP0009931_abnormal_skin_appearance | 0.76839588 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.75580904 |
| 114 | MP0005360_urolithiasis | 0.74119234 |
| 115 | MP0001835_abnormal_antigen_presentation | 0.72208812 |
| 116 | MP0003950_abnormal_plasma_membrane | 0.70922217 |
| 117 | MP0005365_abnormal_bile_salt | 0.70770586 |
| 118 | MP0005621_abnormal_cell_physiology | 0.70716246 |
| 119 | MP0006082_CNS_inflammation | 0.69655101 |
| 120 | MP0002128_abnormal_blood_circulation | 0.69376583 |
| 121 | MP0010368_abnormal_lymphatic_system | 0.69177638 |
| 122 | * MP0001819_abnormal_immune_cell | 0.66971446 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.65839523 |
| 124 | MP0002118_abnormal_lipid_homeostasis | 0.65066329 |
| 125 | MP0005085_abnormal_gallbladder_physiolo | 0.64236938 |
| 126 | MP0002653_abnormal_ependyma_morphology | 0.64200863 |
| 127 | MP0002970_abnormal_white_adipose | 0.63463233 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60271692 |
| 129 | MP0005275_abnormal_skin_tensile | 0.59391353 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.56899813 |
| 131 | MP0005623_abnormal_meninges_morphology | 0.56515864 |
| 132 | MP0009115_abnormal_fat_cell | 0.56429825 |
| 133 | MP0003984_embryonic_growth_retardation | 0.56045385 |
| 134 | MP0002822_catalepsy | 0.55700674 |
| 135 | MP0005334_abnormal_fat_pad | 0.55027864 |
| 136 | MP0008438_abnormal_cutaneous_collagen | 0.54846178 |
| 137 | MP0002088_abnormal_embryonic_growth/wei | 0.54804441 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.54486576 |
| 139 | MP0010329_abnormal_lipoprotein_level | 0.53561330 |
| 140 | MP0004858_abnormal_nervous_system | 0.53387005 |
| 141 | MP0003191_abnormal_cellular_cholesterol | 0.53057123 |
| 142 | MP0003656_abnormal_erythrocyte_physiolo | 0.52044670 |
| 143 | MP0003283_abnormal_digestive_organ | 0.51252465 |
| 144 | MP0003329_amyloid_beta_deposits | 0.49872006 |
| 145 | MP0005535_abnormal_body_temperature | 0.48580689 |
| 146 | MP0005451_abnormal_body_composition | 0.48163830 |
| 147 | MP0000609_abnormal_liver_physiology | 0.48037126 |
| 148 | MP0002139_abnormal_hepatobiliary_system | 0.46466376 |
| 149 | MP0003195_calcinosis | 0.45353909 |
| 150 | MP0002925_abnormal_cardiovascular_devel | 0.43332415 |
| 151 | MP0001849_ear_inflammation | 0.42714701 |
| 152 | MP0001765_abnormal_ion_homeostasis | 0.41276197 |
| 153 | MP0001666_abnormal_nutrient_absorption | 0.41158828 |
| 154 | MP0009672_abnormal_birth_weight | 0.40971509 |
| 155 | MP0001672_abnormal_embryogenesis/_devel | 0.40265239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.58335050 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.05140638 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 5.65843020 |
| 4 | Myoglobinuria (HP:0002913) | 5.49748040 |
| 5 | Ventricular tachycardia (HP:0004756) | 5.46149815 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.25267218 |
| 7 | Muscle fiber splitting (HP:0003555) | 5.06504971 |
| 8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.86539670 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 4.59419549 |
| 10 | Atrial fibrillation (HP:0005110) | 4.39848968 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 4.32649208 |
| 12 | Subaortic stenosis (HP:0001682) | 4.20810002 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.20810002 |
| 14 | Lipoatrophy (HP:0100578) | 4.19614735 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 4.13858107 |
| 16 | Rhabdomyolysis (HP:0003201) | 4.12516491 |
| 17 | Increased connective tissue (HP:0009025) | 4.07237173 |
| 18 | Supraventricular tachycardia (HP:0004755) | 4.04054949 |
| 19 | Asymmetric septal hypertrophy (HP:0001670) | 4.02678335 |
| 20 | Bundle branch block (HP:0011710) | 4.01054033 |
| 21 | Difficulty running (HP:0009046) | 3.99058081 |
| 22 | Supraventricular arrhythmia (HP:0005115) | 3.97734999 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 3.96948081 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.69709258 |
| 25 | Palpitations (HP:0001962) | 3.65684232 |
| 26 | Dilated cardiomyopathy (HP:0001644) | 3.60695758 |
| 27 | Syncope (HP:0001279) | 3.57516477 |
| 28 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.48480692 |
| 29 | Prolonged QT interval (HP:0001657) | 3.38019521 |
| 30 | Difficulty climbing stairs (HP:0003551) | 3.35664630 |
| 31 | Atrioventricular block (HP:0001678) | 3.32744321 |
| 32 | Myotonia (HP:0002486) | 3.32740420 |
| 33 | Heart block (HP:0012722) | 3.31349793 |
| 34 | Vertebral compression fractures (HP:0002953) | 3.30729788 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 3.29864347 |
| 36 | Ventricular arrhythmia (HP:0004308) | 3.28624038 |
| 37 | Ketoacidosis (HP:0001993) | 3.21733242 |
| 38 | Protrusio acetabuli (HP:0003179) | 3.20975373 |
| 39 | Ventricular fibrillation (HP:0001663) | 3.13911235 |
| 40 | Abnormal atrioventricular conduction (HP:0005150) | 3.11514780 |
| 41 | Muscle fiber inclusion bodies (HP:0100299) | 3.00174376 |
| 42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.93508250 |
| 43 | Premature rupture of membranes (HP:0001788) | 2.90896334 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.88308656 |
| 45 | Muscle stiffness (HP:0003552) | 2.84767519 |
| 46 | Stridor (HP:0010307) | 2.83165826 |
| 47 | Increased variability in muscle fiber diameter (HP:0003557) | 2.79594966 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.79093884 |
| 49 | Achilles tendon contracture (HP:0001771) | 2.76615654 |
| 50 | Ketosis (HP:0001946) | 2.73567176 |
| 51 | J-shaped sella turcica (HP:0002680) | 2.72864685 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.70867803 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.70462525 |
| 54 | Bulbar palsy (HP:0001283) | 2.70329301 |
| 55 | Broad face (HP:0000283) | 2.65069210 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.62051863 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.60011721 |
| 58 | Thin bony cortex (HP:0002753) | 2.59044616 |
| 59 | Biconcave vertebral bodies (HP:0004586) | 2.58628624 |
| 60 | Cervical subluxation (HP:0003308) | 2.58520292 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.57845557 |
| 62 | Abnormality of the Achilles tendon (HP:0005109) | 2.52583292 |
| 63 | Ragged-red muscle fibers (HP:0003200) | 2.50987541 |
| 64 | Ulnar bowing (HP:0003031) | 2.49710676 |
| 65 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.49387636 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.49387636 |
| 67 | Abnormal EKG (HP:0003115) | 2.48513056 |
| 68 | Obstructive sleep apnea (HP:0002870) | 2.48242883 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 2.44296135 |
| 70 | Cholecystitis (HP:0001082) | 2.44296135 |
| 71 | Hyperacusis (HP:0010780) | 2.41137843 |
| 72 | Hepatic necrosis (HP:0002605) | 2.40335312 |
| 73 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.37864963 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30451807 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30451807 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30451807 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.30322389 |
| 78 | Nemaline bodies (HP:0003798) | 2.29942283 |
| 79 | Easy fatigability (HP:0003388) | 2.28413030 |
| 80 | Joint stiffness (HP:0001387) | 2.27539555 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26337373 |
| 82 | Mucopolysacchariduria (HP:0008155) | 2.26337373 |
| 83 | EMG: neuropathic changes (HP:0003445) | 2.24296496 |
| 84 | Myopathic facies (HP:0002058) | 2.23619758 |
| 85 | Spinal rigidity (HP:0003306) | 2.23405988 |
| 86 | Neck muscle weakness (HP:0000467) | 2.20956391 |
| 87 | Broad metatarsal (HP:0001783) | 2.19795577 |
| 88 | Dysmetric saccades (HP:0000641) | 2.18362168 |
| 89 | Hyperglycinuria (HP:0003108) | 2.16636013 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.15730621 |
| 91 | Colitis (HP:0002583) | 2.15710954 |
| 92 | Large for gestational age (HP:0001520) | 2.13593135 |
| 93 | Lower limb amyotrophy (HP:0007210) | 2.13186379 |
| 94 | Hyperammonemia (HP:0001987) | 2.12078235 |
| 95 | Hand muscle atrophy (HP:0009130) | 2.11498273 |
| 96 | Areflexia of lower limbs (HP:0002522) | 2.11462071 |
| 97 | Left ventricular hypertrophy (HP:0001712) | 2.10915681 |
| 98 | Testicular atrophy (HP:0000029) | 2.09316184 |
| 99 | Cholelithiasis (HP:0001081) | 2.09062623 |
| 100 | Conjunctival hamartoma (HP:0100780) | 2.09045305 |
| 101 | Increased muscle lipid content (HP:0009058) | 2.08989726 |
| 102 | Generalized amyotrophy (HP:0003700) | 2.07309341 |
| 103 | Gout (HP:0001997) | 2.06951364 |
| 104 | Progressive muscle weakness (HP:0003323) | 2.05399370 |
| 105 | Axonal loss (HP:0003447) | 2.00788722 |
| 106 | Generalized muscle weakness (HP:0003324) | 2.00429120 |
| 107 | Palmoplantar keratoderma (HP:0000982) | 1.98806951 |
| 108 | Athetosis (HP:0002305) | 1.97623945 |
| 109 | Eczematoid dermatitis (HP:0000976) | 1.97568639 |
| 110 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.94963042 |
| 111 | Nuclear cataract (HP:0100018) | 1.94275149 |
| 112 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93099598 |
| 113 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93099598 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93099598 |
| 115 | Cellulitis (HP:0100658) | 1.92453310 |
| 116 | Hamartoma of the eye (HP:0010568) | 1.92171225 |
| 117 | Loss of speech (HP:0002371) | 1.92060371 |
| 118 | Growth hormone excess (HP:0000845) | 1.90569695 |
| 119 | Fragile skin (HP:0001030) | 1.90051809 |
| 120 | Facial diplegia (HP:0001349) | 1.89648552 |
| 121 | Malnutrition (HP:0004395) | 1.88756082 |
| 122 | Pheochromocytoma (HP:0002666) | 1.88034121 |
| 123 | Hypertriglyceridemia (HP:0002155) | 1.87598206 |
| 124 | Upper limb amyotrophy (HP:0009129) | 1.86836465 |
| 125 | Distal upper limb amyotrophy (HP:0007149) | 1.86836465 |
| 126 | Neoplasm of the adrenal gland (HP:0100631) | 1.86431083 |
| 127 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.85580838 |
| 128 | Mitral regurgitation (HP:0001653) | 1.84203693 |
| 129 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83918960 |
| 130 | Distal arthrogryposis (HP:0005684) | 1.82639988 |
| 131 | Blue sclerae (HP:0000592) | 1.82508773 |
| 132 | Hepatocellular necrosis (HP:0001404) | 1.81946636 |
| 133 | Hypertensive crisis (HP:0100735) | 1.81830639 |
| 134 | Lymphangioma (HP:0100764) | 1.81825563 |
| 135 | Neonatal death (HP:0003811) | 1.81805427 |
| 136 | Emphysema (HP:0002097) | 1.81202619 |
| 137 | Abnormality of glycine metabolism (HP:0010895) | 1.79937112 |
| 138 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.79937112 |
| 139 | Increased serum ferritin (HP:0003281) | 1.79198149 |
| 140 | Multiple enchondromatosis (HP:0005701) | 1.78742701 |
| 141 | Abnormal gallbladder morphology (HP:0012437) | 1.78132889 |
| 142 | Ulnar deviation of the wrist (HP:0003049) | 1.77715787 |
| 143 | Round ear (HP:0100830) | 1.77237457 |
| 144 | Frequent falls (HP:0002359) | 1.76365075 |
| 145 | Late onset (HP:0003584) | 1.76052758 |
| 146 | Elbow flexion contracture (HP:0002987) | 1.75911361 |
| 147 | Abnormality of the foot musculature (HP:0001436) | 1.75535190 |
| 148 | Neoplasm of head and neck (HP:0012288) | 1.74723771 |
| 149 | Esophageal neoplasm (HP:0100751) | 1.74723771 |
| 150 | Gowers sign (HP:0003391) | 1.74362556 |
| 151 | Distal lower limb amyotrophy (HP:0008944) | 1.74147991 |
| 152 | Sudden cardiac death (HP:0001645) | 1.73424727 |
| 153 | Gastrointestinal inflammation (HP:0004386) | 1.70467122 |
| 154 | Reticulocytosis (HP:0001923) | 1.70369630 |
| 155 | Shallow orbits (HP:0000586) | 1.69828453 |
| 156 | Nonimmune hydrops fetalis (HP:0001790) | 1.68770104 |
| 157 | Increased cerebral lipofuscin (HP:0011813) | 1.68726206 |
| 158 | Thin ribs (HP:0000883) | 1.67561851 |
| 159 | Atrophic scars (HP:0001075) | 1.66586262 |
| 160 | Fatigue (HP:0012378) | 1.66376626 |
| 161 | Flat acetabular roof (HP:0003180) | 1.65315089 |
| 162 | Abnormality of the thoracic spine (HP:0100711) | 1.65206220 |
| 163 | Increased IgE level (HP:0003212) | 1.65168380 |
| 164 | Deep venous thrombosis (HP:0002625) | 1.64719778 |
| 165 | Purpura (HP:0000979) | 1.64414881 |
| 166 | Ankle clonus (HP:0011448) | 1.64036595 |
| 167 | Gastrointestinal stroma tumor (HP:0100723) | 1.63446730 |
| 168 | Disproportionate tall stature (HP:0001519) | 1.63372932 |
| 169 | Abnormality of complement system (HP:0005339) | 1.62232624 |
| 170 | Gastrointestinal dysmotility (HP:0002579) | 1.62075432 |
| 171 | Cerebral palsy (HP:0100021) | 1.61978377 |
| 172 | Turricephaly (HP:0000262) | 1.61279945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.09385328 |
| 2 | TRIB3 | 4.52812671 |
| 3 | PKN2 | 3.83219026 |
| 4 | LMTK2 | 3.52232613 |
| 5 | BCKDK | 3.43093090 |
| 6 | PHKG2 | 3.32290762 |
| 7 | PHKG1 | 3.32290762 |
| 8 | PDK3 | 3.15280946 |
| 9 | PDK4 | 3.15280946 |
| 10 | OBSCN | 3.01286542 |
| 11 | PRPF4B | 2.91899458 |
| 12 | NEK1 | 2.82475449 |
| 13 | SMG1 | 2.56048049 |
| 14 | IRAK3 | 2.50847146 |
| 15 | NME2 | 2.48123011 |
| 16 | MYLK | 2.30910495 |
| 17 | DMPK | 2.15467012 |
| 18 | TESK1 | 1.96327502 |
| 19 | ERN1 | 1.90658335 |
| 20 | PDK2 | 1.85540141 |
| 21 | TESK2 | 1.82523140 |
| 22 | RIPK1 | 1.71372131 |
| 23 | PINK1 | 1.69791615 |
| 24 | EPHA2 | 1.67837138 |
| 25 | MAP3K10 | 1.61650409 |
| 26 | MAP4K1 | 1.58186215 |
| 27 | ICK | 1.54906889 |
| 28 | MAP3K7 | 1.49296867 |
| 29 | ARAF | 1.47499308 |
| 30 | PRKD3 | 1.47227576 |
| 31 | TBK1 | 1.44408103 |
| 32 | MST1R | 1.40663332 |
| 33 | PDGFRA | 1.36330528 |
| 34 | SIK1 | 1.27520053 |
| 35 | FLT3 | 1.19544835 |
| 36 | TAOK1 | 1.18569598 |
| 37 | MAP3K13 | 1.17301576 |
| 38 | TNK2 | 1.15106923 |
| 39 | MAP2K3 | 1.13318883 |
| 40 | MAPKAPK3 | 1.11787568 |
| 41 | RIPK4 | 1.11245250 |
| 42 | EEF2K | 1.10831212 |
| 43 | TYK2 | 1.07778314 |
| 44 | PIM2 | 1.07305712 |
| 45 | SCYL2 | 1.07226971 |
| 46 | ZAP70 | 1.06526168 |
| 47 | GRK6 | 1.03689352 |
| 48 | ILK | 1.01878000 |
| 49 | MAPK12 | 0.96901098 |
| 50 | WNK4 | 0.95462572 |
| 51 | MAP3K6 | 0.94809343 |
| 52 | TIE1 | 0.94123364 |
| 53 | PRKD1 | 0.92036157 |
| 54 | FGFR4 | 0.91987408 |
| 55 | CDC42BPA | 0.91065467 |
| 56 | MAP2K6 | 0.87990638 |
| 57 | LRRK2 | 0.86577199 |
| 58 | PRKAA1 | 0.86441252 |
| 59 | DAPK3 | 0.86279021 |
| 60 | CDK12 | 0.86264188 |
| 61 | PTK6 | 0.85916850 |
| 62 | MAP3K3 | 0.85061951 |
| 63 | MUSK | 0.83884611 |
| 64 | BLK | 0.82825388 |
| 65 | PIK3CA | 0.82566618 |
| 66 | MAP3K11 | 0.80243109 |
| 67 | PAK3 | 0.79270881 |
| 68 | MAP2K2 | 0.77991558 |
| 69 | LIMK1 | 0.77559105 |
| 70 | STK38 | 0.77445861 |
| 71 | MTOR | 0.72748976 |
| 72 | SIK3 | 0.72127701 |
| 73 | CAMK4 | 0.71337393 |
| 74 | KSR2 | 0.69520737 |
| 75 | CAMK2D | 0.62710446 |
| 76 | MAPK11 | 0.62165168 |
| 77 | NME1 | 0.62152704 |
| 78 | KDR | 0.60504024 |
| 79 | TYRO3 | 0.59861679 |
| 80 | BRAF | 0.58040266 |
| 81 | ROCK1 | 0.57279978 |
| 82 | CAMKK1 | 0.56664591 |
| 83 | CDK4 | 0.56214706 |
| 84 | MAP3K14 | 0.56096928 |
| 85 | MAPK7 | 0.54696869 |
| 86 | IRAK4 | 0.54363041 |
| 87 | MAP3K8 | 0.53113846 |
| 88 | RPS6KL1 | 0.52659143 |
| 89 | RPS6KC1 | 0.52659143 |
| 90 | HIPK2 | 0.52490629 |
| 91 | JAK3 | 0.52377994 |
| 92 | DDR2 | 0.52101726 |
| 93 | IRAK2 | 0.51975672 |
| 94 | CAMK1 | 0.51445344 |
| 95 | RPS6KA6 | 0.50558571 |
| 96 | PRKAA2 | 0.50238602 |
| 97 | RET | 0.50193273 |
| 98 | AKT2 | 0.50106442 |
| 99 | SGK3 | 0.49196561 |
| 100 | PDPK1 | 0.48995287 |
| 101 | ABL2 | 0.47809436 |
| 102 | PRKCH | 0.47012665 |
| 103 | SIK2 | 0.45618985 |
| 104 | DYRK1B | 0.45252146 |
| 105 | MAP3K5 | 0.43936693 |
| 106 | MOS | 0.43369536 |
| 107 | PDK1 | 0.43028438 |
| 108 | MAPK15 | 0.42955541 |
| 109 | PRKD2 | 0.42914188 |
| 110 | STK24 | 0.42808252 |
| 111 | LATS2 | 0.42273062 |
| 112 | TAOK2 | 0.41942523 |
| 113 | PAK6 | 0.41426108 |
| 114 | PRKG2 | 0.41397743 |
| 115 | DAPK1 | 0.40165609 |
| 116 | CSK | 0.39432071 |
| 117 | PTK2B | 0.38887498 |
| 118 | RPS6KA1 | 0.38820592 |
| 119 | DAPK2 | 0.37980290 |
| 120 | IKBKE | 0.37965895 |
| 121 | MET | 0.37454166 |
| 122 | MAP2K4 | 0.36429508 |
| 123 | MAPK4 | 0.36022914 |
| 124 | PAK4 | 0.35671758 |
| 125 | BMX | 0.35623841 |
| 126 | PRKACG | 0.35101373 |
| 127 | CAMK1D | 0.34516549 |
| 128 | EPHB1 | 0.33704613 |
| 129 | MAP3K1 | 0.33474971 |
| 130 | RPS6KA2 | 0.31362049 |
| 131 | MARK2 | 0.30589750 |
| 132 | MAP3K9 | 0.30260436 |
| 133 | UHMK1 | 0.29874696 |
| 134 | PRKACB | 0.29045677 |
| 135 | PTK2 | 0.27868682 |
| 136 | TGFBR2 | 0.27561103 |
| 137 | MAP3K4 | 0.27298145 |
| 138 | CAMK2G | 0.26110702 |
| 139 | ROCK2 | 0.25075198 |
| 140 | ALK | 0.25036882 |
| 141 | FGFR1 | 0.24313170 |
| 142 | STK4 | 0.22701845 |
| 143 | WNK1 | 0.21021192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.80052142 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.79626067 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.19348064 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.63554366 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.27890818 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.10950977 |
| 7 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.94131383 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.84401128 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.59055005 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.54947423 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.48650160 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48611749 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.48089018 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20970852 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.12798770 |
| 16 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.93417301 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.85599105 |
| 18 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.73934328 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.68233405 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.67664665 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61714158 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.48835575 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.43853488 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.43815922 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.35190489 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34485578 |
| 27 | Lysine degradation_Homo sapiens_hsa00310 | 1.33132000 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.32889621 |
| 29 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30704592 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30460674 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.30179665 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26073881 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24839042 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22771744 |
| 35 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.21790460 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.18231490 |
| 37 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15415734 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.14647399 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13545896 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12325717 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11258238 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10535784 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.09813063 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.08361004 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07139403 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.06006579 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05977307 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.03318498 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02678132 |
| 50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.99491056 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96617590 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96168295 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.93568947 |
| 54 | Leishmaniasis_Homo sapiens_hsa05140 | 0.92619023 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.92294097 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91767706 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91585623 |
| 58 | Huntingtons disease_Homo sapiens_hsa05016 | 0.89195676 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87365373 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85652334 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.84996249 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.84423118 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82919448 |
| 64 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82694785 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.81948717 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80243917 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79930143 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.78598875 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78220410 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.77140519 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.75626765 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75272779 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75143940 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.74718233 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74040864 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73927021 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.73873632 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73785036 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73732338 |
| 80 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.72406202 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 0.72237230 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71597072 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.70504662 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70374553 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.70292053 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70079816 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68824534 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67464052 |
| 89 | Influenza A_Homo sapiens_hsa05164 | 0.67156310 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.67137879 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66337799 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65896271 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65328117 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64441390 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64411393 |
| 96 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.63286511 |
| 97 | Hepatitis B_Homo sapiens_hsa05161 | 0.62874198 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.62626059 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62568311 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62049492 |
| 101 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61399661 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60873340 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60676378 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56882263 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56435401 |
| 106 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55466060 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52915396 |
| 108 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52711985 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.52381512 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51722767 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50856819 |
| 112 | Base excision repair_Homo sapiens_hsa03410 | 0.49784474 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49304223 |
| 114 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.48920766 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48247550 |
| 116 | Insulin secretion_Homo sapiens_hsa04911 | 0.48149040 |
| 117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.44996234 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44243440 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43781327 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43692024 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42752993 |
| 122 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42578710 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42551498 |
| 124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.41776961 |
| 125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41553873 |
| 126 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40508676 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39306481 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38776142 |
| 129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38152066 |
| 130 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38128772 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.36021748 |
| 132 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.31750807 |
| 133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31149735 |
| 134 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.31148631 |
| 135 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.30320888 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29136742 |
| 137 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28831030 |
| 138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.27162475 |
| 139 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.27137179 |
| 140 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26200788 |
| 141 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24833191 |
| 142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23307801 |
| 143 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.20945741 |
| 144 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20719140 |
| 145 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.18937425 |
| 146 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.18027953 |
| 147 | Bladder cancer_Homo sapiens_hsa05219 | 0.17843494 |
| 148 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17158201 |
| 149 | Adherens junction_Homo sapiens_hsa04520 | 0.17053860 |
| 150 | Metabolic pathways_Homo sapiens_hsa01100 | 0.16899245 |
| 151 | ABC transporters_Homo sapiens_hsa02010 | 0.16669514 |
| 152 | Amoebiasis_Homo sapiens_hsa05146 | 0.16558438 |
| 153 | Gap junction_Homo sapiens_hsa04540 | 0.15472511 |
| 154 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.15163589 |
| 155 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14080566 |
| 156 | Renin secretion_Homo sapiens_hsa04924 | 0.13589679 |
| 157 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.10860904 |

